NASDAQ:INNV InnovAge (INNV) Stock Price, News & Analysis $7.39 -0.16 (-2.12%) Closing price 05/13/2026 04:00 PM EasternExtended Trading$7.38 0.00 (-0.07%) As of 05/13/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About InnovAge Stock (NASDAQ:INNV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InnovAge alerts:Sign Up Key Stats Today's Range$7.17▼$7.5450-Day Range$7.36▼$10.6052-Week Range$3.13▼$10.69Volume324,051 shsAverage Volume256,353 shsMarket Capitalization$1.00 billionP/E RatioN/ADividend YieldN/APrice Target$7.00Consensus RatingReduce Company Overview InnovAge Holdings, Inc. (NASDAQ:INNV) is a healthcare services company that specializes in caring for seniors through the Program of All-Inclusive Care for the Elderly (PACE). Designed for individuals who are eligible for both Medicare and Medicaid, the PACE model integrates medical care, social services and long-term care—delivered primarily in participants’ homes and community-based centers. InnovAge’s approach centers on interdisciplinary care teams that coordinate everything from primary and specialty medical services to nutritional counseling and recreational activities. The company’s core offerings include comprehensive in-home assessments, physician and nursing services, physical and occupational therapy, prescription medication management, and transportation to medical appointments. InnovAge also manages adult day health centers where participants can receive social engagement activities, meals and group therapy sessions. By combining preventive care and chronic disease management with supportive social services, InnovAge aims to reduce hospitalizations and nursing home admissions among high-risk seniors. Founded in 2014 and headquartered in Denver, Colorado, InnovAge operates a network of PACE centers across California, Colorado and Texas. The company serves urban and rural communities, adapting its care delivery model to address regional demographics and healthcare infrastructure. Supported by a management team with extensive experience in geriatrics, community health and healthcare operations, InnovAge continues to expand its footprint while maintaining regulatory compliance and quality standards set by state and federal authorities.AI Generated. May Contain Errors. Read More InnovAge Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreINNV MarketRank™: InnovAge scored higher than 27% of companies evaluated by MarketBeat, and ranked 769th out of 864 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingReduce Consensus RatingInnovAge has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.Downside RiskInnovAge has a consensus price target of $7.00, representing about 5.3% downside from its current price of $7.39.Amount of Analyst CoverageInnovAge has only been the subject of 3 research reports in the past 90 days.Read more about InnovAge's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth117.65% Earnings GrowthEarnings for InnovAge are expected to grow by 117.65% in the coming year, from $0.17 to $0.37 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is -82.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is -82.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 4.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted0.63% of the float of InnovAge has been sold short.Short Interest Ratio / Days to CoverInnovAge has a short interest ratio ("days to cover") of 4.19.Change versus previous monthShort interest in InnovAge has recently increased by 20.52%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. News and Social Media2.7 / 5News Sentiment0.28 News SentimentInnovAge has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for InnovAge this week, compared to 2 articles on an average week.Search Interest9 people have searched for INNV on MarketBeat in the last 30 days. This is an increase of 80% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added InnovAge to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have not sold or bought any company stock.Percentage Held by Insiders1.00% of the stock of InnovAge is held by insiders.Percentage Held by Institutions12.26% of the stock of InnovAge is held by institutions.Read more about InnovAge's insider trading history. Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INNV Stock News HeadlinesWhy InnovAge Holding (INNV) Is Down 9.0% After Raising 2026 Revenue Guidance Amid Wider LossMay 13 at 12:23 AM | finance.yahoo.comInnovAge Appoints Jennifer Browne as President and COOMay 12 at 6:30 PM | tipranks.comMillionaire warns: Move your money nowLarry Benedict, the hedge fund trader who generated $274 million in profits for clients and beat the S&P 500 by 18 times in 2025, says Trump's installation of a new Federal Reserve chair is triggering the most significant shift in U.S. markets in nearly 20 years. Benedict's track record around Fed moves is hard to ignore - 62% from a single position after 2020 rate cuts, 117% in under a month when rate hikes were signaled in 2022, and an 89% gain in 17 days following a Jackson Hole speech. He has already identified the one ticker he believes will be at the center of the coming money flows, and he's sharing it free.May 14 at 1:00 AM | Brownstone Research (Ad)InnovAge Appoints Jennifer Browne as President and Chief Operating OfficerMay 12 at 4:30 PM | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Climb Bio (CLYM) and InnovAge Holding (INNV)May 8, 2026 | theglobeandmail.comInnovAge (INNV) Q3 2026 Earnings TranscriptMay 6, 2026 | finance.yahoo.comInnovAge projects $950M-$975M revenue and $85M-$90M adjusted EBITDA for fiscal 2026 amid early 2027 rate pressure signalsMay 5, 2026 | msn.comInnovAge Holding Corp. (INNV) Q3 2026 Earnings Call TranscriptMay 5, 2026 | seekingalpha.comSee More Headlines INNV Stock Analysis - Frequently Asked Questions How have INNV shares performed this year? InnovAge's stock was trading at $5.19 at the beginning of 2026. Since then, INNV stock has increased by 42.4% and is now trading at $7.39. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (NASDAQ:INNV) released its quarterly earnings data on Tuesday, May, 5th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of $0.06 by $0.28. The company earned $251.94 million during the quarter, compared to analyst estimates of $234.35 million. InnovAge had a negative net margin of 1.22% and a negative trailing twelve-month return on equity of 4.73%. Read the conference call transcript. When did InnovAge IPO? InnovAge (INNV) raised $342 million in an initial public offering on Thursday, March 4th 2021. The company issued 16,666,667 shares at a price of $20.00-$21.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup served as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers. Who are InnovAge's major shareholders? Top institutional shareholders of InnovAge include Hillsdale Investment Management Inc. (0.39%), Ritholtz Wealth Management (0.18%), Dimensional Fund Advisors LP (0.17%) and Welch Capital Partners LLC NY (0.15%). Insiders that own company stock include Nicole Damato, Michael Anthony Scarbrough, Richard C Zoretic and Richard C Zoretic. View institutional ownership trends. How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InnovAge own? Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include EEStor Co. (ESU.V) (ESU), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META) and Netflix (NFLX). Company Calendar Last Earnings5/05/2026Today5/14/2026Fiscal Year End6/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 INNV's financial health is in the Green zone, according to TradeSmith. INNV has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:INNV Previous SymbolOTCMKTS:INNV CIK1834376 Webwww.innovage.com Phone844-803-8745FaxN/AEmployees2,440Year Founded1990Price Target and Rating Average Price Target for InnovAge$7.00 High Price Target$7.00 Low Price Target$7.00 Potential Upside/Downside-5.3%Consensus RatingReduce Rating Score (0-4)1.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.09) Trailing P/E RatioN/A Forward P/E Ratio43.47 P/E GrowthN/ANet Income-$30.31 million Net Margins-1.22% Pretax Margin-1.43% Return on Equity-4.73% Return on Assets-2.20% Debt Debt-to-Equity Ratio0.26 Current Ratio1.03 Quick Ratio1.26 Sales & Book Value Annual Sales$853.70 million Price / Sales1.18 Cash FlowN/A Price / Cash FlowN/A Book Value$1.71 per share Price / Book4.32Miscellaneous Outstanding Shares135,740,000Free Float134,379,000Market Cap$1.00 billion OptionableOptionable Beta0.49 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:INNV) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersOne coin wired into Elon's visionThe Kevin Warsh Fed takeover is here. And he's brought a thesis with him that almost nobody is talking about. ...Crypto 101 Media | SponsoredRead this or regret it foreverThree Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredCollect $1,170 a month from silverI've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...Investors Alley | SponsoredElon’s Biggest Launch Ever: 15x Bigger Than SpaceXThe Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...InvestorPlace | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
